Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01074554
What this trial is testing

Trial of Antimycobacterial Therapy in Sarcoidosis

Who this might be right for
Sarcoidosis
Vanderbilt University 30
Large-scale testing (Phase 3)Study completedNCT01230983
What this trial is testing

Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma

Who this might be right for
Cardiac ToxicityLeukemiaLymphoma
Children's Oncology Group 573
Not applicableWithdrawnNCT07060183
What this trial is testing

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study

Who this might be right for
Moderate Aortic Valve Stenosis
Dermed Diagnostics, Inc.
Not applicableStudy completedNCT07673666
What this trial is testing

GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3)

Who this might be right for
GliomaGlioma (Diagnosis)Astrocytoma+4 more
Deep Learning Institute of Radiological Sciences 1,372
Early research (Phase 1)Study completedNCT00001683
What this trial is testing

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Who this might be right for
LymphomaMelanomaNeoplasm Metastasis+1 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00536341
What this trial is testing

Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
SCRI Development Innovations, LLC 64
Not applicableStudy completedNCT05498402
What this trial is testing

Effect of IAM With an I-gel® on Ventilation Parameters in Simulated Pediatric OHCA

Who this might be right for
Pediatric ALLCardiac ArrestCardiopulmonary Arrest+2 more
Geneve TEAM Ambulances 34
Early research (Phase 1)Not Yet RecruitingNCT06666153
What this trial is testing

Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases

Who this might be right for
CAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromePTLDs
West China Hospital 27
Not applicableUnknownNCT06509945
What this trial is testing

Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Early research (Phase 1)Study completedNCT04656795
What this trial is testing

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Who this might be right for
Renal ImpairmentNormal Renal Function
Tanabe Pharma America, Inc. 32
Not applicableLooking for participantsNCT07751783
What this trial is testing

Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations

Who this might be right for
CancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Lung Cancer (Non-Small Cell)+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 150
Early research (Phase 1)Looking for participantsNCT05010005
What this trial is testing

Ruxolitinib and Duvelisib in People With Lymphoma

Who this might be right for
T-cell LymphomasNK-Cell LymphomasT-cell Prolymphocytic Leukemia+1 more
Memorial Sloan Kettering Cancer Center 70
Early research (Phase 1)Looking for participantsNCT03110822
What this trial is testing

Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Who this might be right for
Multiple Myeloma
Oncotherapeutics 134
Large-scale testing (Phase 3)UnknownNCT00725231
What this trial is testing

Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP

Who this might be right for
Peripheral T Cell Lymphoma, UnspecifiedAngioimmunoblastic LymphadenopathyExtranodal NK/T-cell Lymphoma
University of Göttingen 274
Testing effectiveness (Phase 2)Study completedNCT03264131
What this trial is testing

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Who this might be right for
LymphomaAdult T-Cell Leukemia/LymphomaLymphatic Diseases
UNC Lineberger Comprehensive Cancer Center 16
Large-scale testing (Phase 3)Ended earlyNCT00657553
What this trial is testing

Preemptive Strike With Bortezomib in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Not applicableLooking for participantsNCT07472972
What this trial is testing

Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)

Who this might be right for
LymphomaLymphoid Hematological Malignancies
University of Zurich 50
Not applicableStudy completedNCT01148927
What this trial is testing

Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
University Health Network, Toronto 29
Large-scale testing (Phase 3)Study completedNCT00002561
What this trial is testing

Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease

Who this might be right for
Hodgkin Lymphoma
NCIC Clinical Trials Group 405
Early research (Phase 1)Ended earlyNCT00744354
What this trial is testing

Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
UNC Lineberger Comprehensive Cancer Center 32
Next Page